Publication:
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic.

Simple item page
dc.contributor.authorMontero-Vilchez, Trinidad
dc.contributor.authorMartinez-Lopez, Antonio
dc.contributor.authorSalvador-Rodriguez, Luis
dc.contributor.authorMolina-Leyva, Alejandro
dc.contributor.authorArias-Santiago, Salvador
dc.date.accessioned2023-02-09T09:35:46Z
dc.date.available2023-02-09T09:35:46Z
dc.date.issued2020-06-17
dc.description.abstractThe recent coronavirus disease 2019 (COVID-19) pandemic, caused by the Severe acute respiratory syndrome-associated coronavirus type 2 (SARS-CoV-2) virus, has spread all over the world. As of April 21, 2020, there were 2 478 948 cases of infection, of which 652 046 have resolved, and 170 399 people have died in 185 different countries. The elderly and people with underlying conditions such as cardiovascular disease, obesity, diabetes or cancer are at the highest risk of infection and prone to serious outcomes.
dc.description.versionSi
dc.identifier.citationMontero-Vilchez T, Martinez-Lopez A, Salvador-Rodriguez L, Molina-Leyva A, Arias-Santiago S. Management of patients with hidradenitis suppurativa during the COVID-19 pandemic. Dermatol Ther. 2020 Nov;33(6):e13875.
dc.identifier.doi10.1111/dth.13875
dc.identifier.essn1529-8019
dc.identifier.pmcPMC7323050
dc.identifier.pmid32558071
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323050/pdf
dc.identifier.unpaywallURLhttps://europepmc.org/articles/pmc7323050?pdf=render
dc.identifier.urihttp://hdl.handle.net/10668/15769
dc.issue.number6
dc.journal.titleDermatologic therapy
dc.journal.titleabbreviationDermatol Ther
dc.language.isoen
dc.organizationHospital Universitario Virgen de las Nieves
dc.organizationHospital Universitario Virgen de las Nieves
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number2
dc.provenanceRealizada la curación de contenido 19/07/2024
dc.publisherHindawi Limited
dc.pubmedtypeLetter
dc.relation.publisherversionhttps://doi.org/10.1111/dth.13875
dc.rights.accessRightsRestricted Access
dc.subjectHidradenitis Suppurativa
dc.subjectAged
dc.subjectCardiovascular Diseases
dc.subjectPandemics
dc.subjectDeath
dc.subjectObesity
dc.subject.decsHidradenitis supurativa
dc.subject.decsSARS-CoV-2
dc.subject.decsHumanos
dc.subject.meshCOVID-19
dc.subject.meshHidradenitis Suppurativa
dc.subject.meshHumans
dc.subject.meshSARS-CoV-2
dc.titleManagement of patients with hidradenitis suppurativa during the COVID-19 pandemic.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number33
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC7323050.pdf
Size:
385.94 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen de las Nieves
Instituto de Investigación Biosanitaria de Granada (ibsGRANADA)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía